The Transforming Principle

Foundations | The Transforming Principle Click for larger version (74K) On May 13th, 1943, Oswald T. Avery (1877-1945) wrote a 14-page meandering letter to his brother Roy about his research, his despondence, his fears, and his dreams. His emotions range from excited explanation of what was happening in his lab to trepidations that the scientific community wouldn't accept his results. At one point, Avery questions whether he should leave the Rockefeller Institute, give up science, and retu

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

On May 13th, 1943, Oswald T. Avery (1877-1945) wrote a 14-page meandering letter to his brother Roy about his research, his despondence, his fears, and his dreams. His emotions range from excited explanation of what was happening in his lab to trepidations that the scientific community wouldn't accept his results. At one point, Avery questions whether he should leave the Rockefeller Institute, give up science, and return to his native Tennessee. About a year after he sent this correspondence, Avery published his landmark genetics paper in which he proved that deoxyribose nucleic acid contains heritable genetic data.1

Oswald's letter transcribed: ... Sounds like a virus--may be a gene. But with mechanisms I am not now concerned--One step at a time--and the first is what is the chemical nature of the transforming principle? Someone else can work out the rest. Of course the problem bristles with implications. It touches the biochemistry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform